Calendar BrightPath Biotherapeutics Co., Ltd.

Equities

4594

JP3274140007

Delayed Japan Exchange 09:25:22 2024-04-24 pm EDT 5-day change 1st Jan Change
60 JPY +1.69% Intraday chart for BrightPath Biotherapeutics Co., Ltd. +3.45% -31.03%

Chart calendar BrightPath Biotherapeutics Co., Ltd.

41badff94b580.TDyYkeztKf_BiZqoxX3GvxLB56N3rH4oaUgdl5yqnkQ.E2XWoLSAHs3w7MzCvzS8z2GmgPQ08xxqCABV3djr-Aw_W_3VppRjqau_7Q~e917e03d4333242e83cd801deaf6c4bb

Upcoming events on BrightPath Biotherapeutics Co., Ltd.

2024-05-09 Q4 2023 Earnings Release
2024-08-08 Q1 2024 Earnings Release (Projected)
2024-11-07 Q2 2024 Earnings Release (Projected)
2025-02-06 Q3 2024 Earnings Release (Projected)
2025-05-08 Q4 2025 Earnings Release (Projected)

Past events on BrightPath Biotherapeutics Co., Ltd.

2024-02-08 Q3 2023 Earnings Release
2023-11-09 Q2 2023 Earnings Release
2023-08-09 Q1 2023 Earnings Release
2023-05-11 Q4 2022 Earnings Release
2023-02-09 Q3 2022 Earnings Release
2022-11-10 Interim 2022 Earnings Release
2022-08-11 Q1 2022 Earnings Release
2022-05-11 FY 2021 Earnings Release
2022-02-09 Q3 2022 Earnings Release
2021-11-11 Interim 2021 Earnings Release
2021-08-12 Q1 2021 Earnings Release
2021-05-12 FY 2020 Earnings Release
2021-02-11 Q3 2020 Earnings Release
2020-11-12 Interim 2020 Earnings Release
2020-08-06 Q1 2020 Earnings Release
2020-05-14 FY 2019 Earnings Release
2020-02-13 Q3 2019 Earnings Release
2019-11-07 Interim 2019 Earnings Release
2019-08-08 Q1 2019 Earnings Release
2019-05-09 FY 2018 Earnings Release

Annual results

Fiscal PeriodMarch 2017 2018
Net sales
Million JPY
Released
Forecast
Spread
529


354


EBITDA
Million JPY
Released
Forecast
Spread
-1 072


0,00


EBIT
Million JPY
Released
Forecast
Spread
-1 113


-1 561


Earnings before Tax (EBT)
Million JPY
Released
Forecast
Spread
-1 116


-1 573


Net income
Million JPY
Released
Forecast
Spread
-1 113


-1 577


EPS
JPY
Released
Forecast
Spread
-32,7


-41,3


Announcement Date12/05/1711/05/18
  1. Stock Market
  2. Equities
  3. 4594 Stock
  4. Calendar BrightPath Biotherapeutics Co., Ltd.